Skip to content

Novel Prognostic Tool for ER+ Breast Cancer

Glucocorticoid Receptor promoter methylation has both positive and negative prognostic value for ER+ breast cancer patients

Published: 18th May 2021
Novel Prognostic Tool for ER+ Breast Cancer
arcyto, stock.adobe.com
IP Status
  • Patented
Seeking
  • Development partner
  • Commercial partner
  • Licensing
  • Seeking investment